Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Equity Income (2018 - 2020)

Historic Equity Income for Arcus Biosciences (RCUS) over the last 3 years, with Q4 2020 value amounting to $1.2 million.

  • Arcus Biosciences' Equity Income changed N/A to $1.2 million in Q4 2020 from the same period last year, while for Jun 2021 it was $1.2 million, marking a year-over-year increase of 22639.18%. This contributed to the annual value of $613000.0 for FY2020, which is 15099.83% up from last year.
  • Arcus Biosciences' Equity Income amounted to $1.2 million in Q4 2020.
  • In the past 5 years, Arcus Biosciences' Equity Income registered a high of $1.2 million during Q4 2020, and its lowest value of -$482000.0 during Q1 2020.
  • Moreover, its 3-year median value for Equity Income was -$274500.0 (2018), whereas its average is -$147300.0.
  • Its Equity Income has fluctuated over the past 5 years, first plummeted by 17284.77% in 2019, then soared by 6820.39% in 2020.
  • Arcus Biosciences' Equity Income (Quarter) stood at -$323000.0 in 2018, then decreased by 10.53% to -$357000.0 in 2019, then soared by 443.42% to $1.2 million in 2020.
  • Its Equity Income stands at $1.2 million for Q4 2020, versus -$131000.0 for Q2 2020 and -$482000.0 for Q1 2020.